An elevation in the urine levels of IL-8, CXCL 10, BDNF, IL-6, and RANTES in IC/BPS patients should prompt physicians to consider the diagnosis of HIC, and potentially initiate early treatment. This evidence concerns the gene CCL5 and Bartsocas-Papas syndrome 1.